Month: May 2021

NOVA LIMA, MINAS GERAIS, Brazil, May 03, 2021 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report first quarter 2021 financial results for the period ended March 31, 2021, following the close of the market on Thursday, May 27, 2020. The Company will host a corresponding conference call and webcast on May 28 at 11:00 AM EDT. Dialing numbers for the conference will be disclosed soon. A live and archived webcast of the call will be available on the Investor Relations section of the Company’s website at https://ir.afya.com.br/. About Afya Limited (Nasdaq: AFYA) Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners from the moment they join...

Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., May 03, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that the company will release its first quarter 2021 financial results after the market closes on Monday, May 17, 2021. Management will host a conference call with a slide presentation at 5:00 p.m. ET (2:00 p.m. PT) on the same day to provide an update on the company’s business. Details for the Conference Call and Slide Presentation: Date: May 17, 2021Time: 5:00 p.m. ET (2:00 p.m. PT) Conference AudioDial-in U.S. and Canada: (877) 451-6152 Dial-in International: (201) 389-0879 Conference ID No.: 13718702Slide PresentationPlease visit...

Reservations for Mother’s Day are up 9X Compared to 2020 Showing a Strong Appetite for Dining Out with Loved Ones; OpenTable Partners with Select Restaurants Nationwide to Offer Diners Long Overdue Family Photos SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) — According to data from OpenTable, the world’s leading provider of online restaurant reservations and part of Booking Holdings Inc. (NASDAQ: BKNG), Mother’s Day reservations are up 64% compared to 2019 (pre-pandemic levels), indicating strong demand for dining out with loved ones again. In fact, a recent survey* conducted by OpenTable showed one in three Americans haven’t had an extended family gathering in over a year and 63% either haven’t had a professional family picture in that time or can’t remember the last time they had one taken. To help families capture their...

SAN ANTONIO, May 03, 2021 (GLOBE NEWSWIRE) — Usio, Inc. (Nasdaq: USIO), an integrated electronic payment solutions provider, today announced that it will release first quarter financial results for the period ended March 31, 2021 after the market closes on Thursday, May 13, 2021. Usio’s management will host a conference call Friday, May 14, 2021 at 11:00 a.m. Eastern time to review financial results and provide a business update. Following management’s formal remarks, there will be a question and answer session. To listen to the conference call, interested parties within the U.S. should call 1-844-883-3890. International callers should call 1-412-317-9246. All callers should ask for the Usio conference call. The conference call will also be available through a live webcast, which can be accessed via the company’s website at www.usio.com/investors. A...

CHARLOTTE, N.C., May 03, 2021 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) today announced that wealth management professionals at Kraner, LLC have joined LPL Financial, aligning with Independent Network of Consultants & Advisors (INC Advisors), an existing large enterprise serving LPL-affiliated advisors. The team reported having served more than $200 million in advisory, brokerage and retirement plan assets*, and joins LPL from Voya Financial Advisors. CEO and President Vladislav (Vlad) Zherenovsky founded the firm in 2010, choosing his mother’s maiden name, Kraner, for his business. With its main office in Montvale, N.J., and employees throughout N.J. and Iowa, Zherenovsky is joined by Wealth Advisor Nicholas Choman, Chartered Retirement Planning Counselor (CRPC), Certified Fund Specialist (CFS), and four support...

Two-day summit will feature guest speakers including Shark Tank’s Kevin O’Leary and Nerd’s Eye View Publisher Michael Kitces CONCORD, Calif., May 03, 2021 (GLOBE NEWSWIRE) — AssetMark (NYSE: AMK) today announced the first AssetMark Institutional RIA Summit. The RIA Summit will bring together thought leaders from across the industry covering a range of topics that matter to RIAs at any stage, from launching an advisory firm to fine tuning an existing practice, to preparing for mergers and acquisitions. The Summit features insights from leaders in the investment space, including Shark Tank’s Kevin O’Leary, and Nerd’s Eye View Publisher Michael Kitces. The free, virtual, two-day event will take place on Tuesday, May 25 and Wednesday, May 26. Insights from the RIA community will include:Latest trends impacting the independent...

FORT WAYNE, Ind., May 03, 2021 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced that it plans to report results for the first quarter ended May 1, 2021 at 8:00 a.m. Eastern Time on Wednesday, June 9, 2021. The Company will host a conference call to discuss its financial results at 9:30 a.m. Eastern Time that same day. A live webcast of the conference call will be available on the Investor Relations section of the Company’s website, www.verabradley.com. Alternatively, interested parties may dial into the call at (800) 289-0571, and enter the access code 6021253. A replay will be available shortly after the conclusion of the call and remain available through June 23, 2021. To access the recording, listeners should dial (844) 512-2921, and enter the access code 6021253. ABOUT VERA BRADLEY, INC. Vera...

VANCOUVER, British Columbia, May 03, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”) is pleased to provide the following corporate update. We are extremely pleased to report that even though the Covid-19 pandemic continues to impact numerous business operations and even society itself, our enterprise has not only survived, but we are also thriving and growing. With the early adoption of workplace anti-viral protocols in-place, we are proud to report that there have been no cases of Covid-19 at our facility despite our proximity to Whistler Village which has been hard hit by the pandemic. We sincerely offer our best wishes and thanks to our frontline workers across the nation and our thoughts are with all who have felt the impact of this awful disease....

SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today a new ELISA test that measures levels of neutralizing antibodies against six common variants of SARS-CoV-2 virus. The Company has also filed for patent protection for the diagnostic test. SARS-CoV-2 variants from Brazil, South Africa, California and Britain have been shown to be more infectious and potentially more deadly than the original Wuhan strain due to mutations in the viral spike protein. This has caused concern because current COVID-19 vaccines are based on the spike protein in the Wuhan strain and it is not known how well the vaccines protect against the other variants. AXIM Biotechnologies...

Following the successful conclusion of three clinical trials, approximately 120 patients continue treatment with leronlimab in extension arms VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (Vyrologix™ or PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today a comprehensive update on three continuing extension studies with leronlimab as a treatment for HIV. Chris Recknor, M.D., CytoDyn’s Chief Operating Officer, commented, “We are still on schedule for rolling submission of the HIV BLA in July of this year. Clinical results from multiple trials show that Vyrologix can significantly reduce the viral burden in people infected with HIV. Moreover, a Phase 2 clinical...